Correlation Between Arcus Biosciences and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Blueprint Medicines Corp, you can compare the effects of market volatilities on Arcus Biosciences and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Blueprint Medicines.
Diversification Opportunities for Arcus Biosciences and Blueprint Medicines
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Arcus and Blueprint is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Blueprint Medicines
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 3.21 times less return on investment than Blueprint Medicines. In addition to that, Arcus Biosciences is 1.37 times more volatile than Blueprint Medicines Corp. It trades about 0.02 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.08 per unit of volatility. If you would invest 5,873 in Blueprint Medicines Corp on September 1, 2024 and sell it today you would earn a total of 3,765 from holding Blueprint Medicines Corp or generate 64.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Arcus Biosciences vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Arcus Biosciences |
| Blueprint Medicines Corp |
Arcus Biosciences and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Arcus Biosciences and Blueprint Medicines
The main advantage of trading using opposite Arcus Biosciences and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Arcus Biosciences vs. Cullinan Oncology LLC | Arcus Biosciences vs. Annexon | Arcus Biosciences vs. Structure Therapeutics American | Arcus Biosciences vs. Relay Therapeutics |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |